Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

SZSE Ticker: 300463

Maccura Biotechnology Co., Ltd

迈克生物股份有限公司

迈克生物

MAKER BIOTECHNOLOGY

Listing Date: 2015-05-28

Board: GEM

Industry Classification: Manufacturing

Ranking list of fixed increase in fundraising during the year: 9 companies raised more than 5 billion yuan – yqqlm

  • Post date May 16, 2022 — 17:30 Post Lock Login to View

Read More

Tens of thousands of monthly salary! The position of nucleic acid sampler is on fire, and the opportunity for robots is here – yqqlm

  • Post date May 16, 2022 — 00:29 Post Lock Login to View

Read More

The scale of the allocation is nearly halved, and the public offering has cooled down a lot

  • Post date May 15, 2022 — 01:05 Post Lock Login to View

Read More

Mike Bio: No plans to deploy nucleic acid sampling booths at the moment IT News

  • Post date May 12, 2022 — 20:37 Post Lock Login to View

Read More

Mike Bio (300463): 2021 Annual Equity Distribution Implementation Announcement CFi.CN Zhongcai Network

  • Post date May 12, 2022 — 20:16 Post Lock Login to View

Read More

Rumors of "false positives" once forced the stock price of Runda Medical to stop: regulatory intervention to investigate the differentiation of nucleic acid detection sector into new coronary pneumonia jqknews

  • Post date May 10, 2022 — 19:03 Post Lock Login to View

Read More

The "false positive" rumors once forced the stock price of Runda to stop! Regulatory involvement in the investigation, the nucleic acid detection sector is differentiated – yqqlm

  • Post date May 10, 2022 — 18:49 Post Lock Login to View

Read More

The urban "track" changed by the epidemic Yahui.com

  • Post date May 9, 2022 — 23:35 Post Lock Login to View

Read More

The urban "track" changed by the epidemic Yahui.com

  • Post date May 9, 2022 — 23:35 Post Lock Login to View

Read More

Behind China's 11.5 billion nucleic acid tests: the life and death situation of enterprises

  • Post date May 5, 2022 — 22:13 Post Lock Login to View

Read More

Celebrity private equity adjustment routes in the first quarter are exposed! Gao Yi and Feng Liu cut positions in pharmaceutical stocks, and Deng Xiaofeng bucked the trend and increased positions in these stocks… The "mysterious" private equity of Maotai, a heavy warehouse, also shot Rongyi Financial Information Rongyi Information Network

  • Post date May 4, 2022 — 17:36 Post Lock Login to View

Read More

Celebrity private equity adjustment routes in the first quarter are exposed! Gao Yi and Feng Liu cut positions in pharmaceutical stocks, and Deng Xiaofeng bucked the trend and increased positions in these stocks… The "mysterious" private equity of Maotai, a heavy warehouse, also shot Rongyi Financial Information Rongyi Information Network

  • Post date May 4, 2022 — 16:30 Post Lock Login to View

Read More

Celebrity private equity adjustment routes in the first quarter are exposed! Gao Yi and Feng Liu cut positions in pharmaceutical stocks, and Deng Xiaofeng bucked the trend and increased positions in these stocks… The "mysterious" private equity of Maotai, a heavy warehouse, also shot Rongyi Financial Information Rongyi Information Network

  • Post date May 4, 2022 — 15:05 Post Lock Login to View

Read More

Celebrity private equity adjustment route in the first quarter exposed! Gao Yi and Feng Liu cut positions in pharmaceutical stocks, and Deng Xiaofeng bucked the trend and increased positions in these stocks… The "mysterious" private equity of Shigekura Moutai also took action – yqqlm

  • Post date May 3, 2022 — 03:25 Post Lock Login to View

Read More

Celebrity private equity adjustment routes in the first quarter are exposed! Gao Yi and Feng Liu cut positions in pharmaceutical stocks, and Deng Xiaofeng bucked the trend and increased positions in these stocks…-Finance-

  • Post date May 3, 2022 — 01:37 Post Lock Login to View

Read More

Celebrity private equity adjustment routes in the first quarter are exposed! Gao Yi and Feng Liu cut positions in pharmaceutical stocks, and Deng Xiaofeng bucked the trend and increased positions in these stocks… The "mysterious" private equity of Maotai, a heavy warehouse, also shot.

  • Post date May 3, 2022 — 01:31 Post Lock Login to View

Read More

Behind China's 11.5 billion nucleic acid tests: from 200 yuan to 20 yuan, can companies still make money? Kit for Genetic Detection of Microorganisms

  • Post date May 3, 2022 — 01:18 Post Lock Login to View

Read More

The latest private equity fund news: star private equity adjustment route in the first quarter exposed! Gao Yi and Feng Liu cut positions in pharmaceutical stocks, and Deng Xiaofeng bucked the trend and increased positions in these stocks… The "mysterious" private equity of Maotai, a heavy warehouse, also shot Yahui.com

  • Post date May 3, 2022 — 00:16 Post Lock Login to View

Read More

The latest private equity fund news: star private equity adjustment route in the first quarter exposed! Gao Yi and Feng Liu cut positions in pharmaceutical stocks, and Deng Xiaofeng bucked the trend and increased positions in these stocks… The "mysterious" private equity of Maotai, a heavy warehouse, also shot Yahui.com

  • Post date May 2, 2022 — 23:35 Post Lock Login to View

Read More

Celebrity private equity adjustment routes in the first quarter are exposed! Gao Yi and Feng Liu cut positions in pharmaceutical stocks, and Deng Xiaofeng bucked the trend and increased positions in these stocks… The "mysterious" private equity of Maotai, a heavy warehouse, also shot! -Private-Finance

  • Post date May 2, 2022 — 20:50 Post Lock Login to View

Read More

Want to see more data? Registered subscribers can see all the data.

   Register Now!
  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.